Alysson R. Muotri, PhD,
Aprovada primeira droga para mutações em CDKL5 😀!
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial
Overview of attention for article published in Lancet Neurology, May 2022
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (97th percentile)
-
High Attention Score compared to outputs of the same age and source (87th percentile)
Mentioned by
- news
- 10 news outlets
- blogs
- 2 blogs
- 36 X users
- 1 Facebook page
- wikipedia
- 1 Wikipedia page
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 171 Mendeley